@article{ hebsur_influenza_2014,
  title = {Influenza and coronary artery disease: exploring a clinical association with myocardial infarction and analyzing the utility of vaccination in prevention of myocardial infarction},
  volume = {15},
  issn = {1530-6550},
  shorttitle = {Influenza and coronary artery disease},
  abstract = {Both coronary artery disease and influenza outbreaks contribute significantly to worldwide morbidity and mortality. An increasing number of epidemiologic studies have concluded that a temporal association exists between acute viral illnesses and myocardial infarction. Viral illnesses such as influenza can cause or exacerbate coronary atherosclerosis by activating inflammatory pathways. Data from a large case-controlled trial and two randomized controlled trials suggest that influenza vaccination in patients with coronary artery disease may lead to a decrease in incidence, morbidity, and mortality from acute myocardial infarction. A meta-analysis of the two randomized controlled trials for cardiovascular death demonstrated a pooled relative risk of 0.39 (95% confidence interval, 0.20-0.77) for patients who received the influenza vaccine compared with placebo.},
  language = {eng},
  number = {2},
  journal = {Reviews in Cardiovascular Medicine},
  author = {Hebsur, Shrinivas and Vakil, Erik and Oetgen, William J. and Kumar, Princy N. and Lazarous, Daisy F.},
  year = {2014},
  pmid = {25051134},
  keywords = {Humans, Inflammation, Influenza Vaccines, Influenza, Human, Myocardial Infarction, Prognosis, Risk Factors, Vaccination},
  pages = {168--175}
}

{"_id":"55sYd9gvkm93pvbxt","bibbaseid":"hebsur-vakil-oetgen-kumar-lazarous-influenzaandcoronaryarterydiseaseexploringaclinicalassociationwithmyocardialinfarctionandanalyzingtheutilityofvaccinationinpreventionofmyocardialinfarction-2014","downloads":0,"creationDate":"2015-09-07T06:52:48.360Z","title":"Influenza and coronary artery disease: exploring a clinical association with myocardial infarction and analyzing the utility of vaccination in prevention of myocardial infarction","author_short":["Hebsur, S.","Vakil, E.","Oetgen, W.<nbsp>J.","Kumar, P.<nbsp>N.","Lazarous, D.<nbsp>F."],"year":2014,"bibtype":"article","biburl":"http://bibbase.org/zotero/vdec","bibdata":{"abstract":"Both coronary artery disease and influenza outbreaks contribute significantly to worldwide morbidity and mortality. An increasing number of epidemiologic studies have concluded that a temporal association exists between acute viral illnesses and myocardial infarction. Viral illnesses such as influenza can cause or exacerbate coronary atherosclerosis by activating inflammatory pathways. Data from a large case-controlled trial and two randomized controlled trials suggest that influenza vaccination in patients with coronary artery disease may lead to a decrease in incidence, morbidity, and mortality from acute myocardial infarction. A meta-analysis of the two randomized controlled trials for cardiovascular death demonstrated a pooled relative risk of 0.39 (95% confidence interval, 0.20-0.77) for patients who received the influenza vaccine compared with placebo.","author":["Hebsur, Shrinivas","Vakil, Erik","Oetgen, William J.","Kumar, Princy N.","Lazarous, Daisy F."],"author_short":["Hebsur, S.","Vakil, E.","Oetgen, W.<nbsp>J.","Kumar, P.<nbsp>N.","Lazarous, D.<nbsp>F."],"bibtex":"@article{ hebsur_influenza_2014,\n title = {Influenza and coronary artery disease: exploring a clinical association with myocardial infarction and analyzing the utility of vaccination in prevention of myocardial infarction},\n volume = {15},\n issn = {1530-6550},\n shorttitle = {Influenza and coronary artery disease},\n abstract = {Both coronary artery disease and influenza outbreaks contribute significantly to worldwide morbidity and mortality. An increasing number of epidemiologic studies have concluded that a temporal association exists between acute viral illnesses and myocardial infarction. Viral illnesses such as influenza can cause or exacerbate coronary atherosclerosis by activating inflammatory pathways. Data from a large case-controlled trial and two randomized controlled trials suggest that influenza vaccination in patients with coronary artery disease may lead to a decrease in incidence, morbidity, and mortality from acute myocardial infarction. A meta-analysis of the two randomized controlled trials for cardiovascular death demonstrated a pooled relative risk of 0.39 (95% confidence interval, 0.20-0.77) for patients who received the influenza vaccine compared with placebo.},\n language = {eng},\n number = {2},\n journal = {Reviews in Cardiovascular Medicine},\n author = {Hebsur, Shrinivas and Vakil, Erik and Oetgen, William J. and Kumar, Princy N. and Lazarous, Daisy F.},\n year = {2014},\n pmid = {25051134},\n keywords = {Humans, Inflammation, Influenza Vaccines, Influenza, Human, Myocardial Infarction, Prognosis, Risk Factors, Vaccination},\n pages = {168--175}\n}","bibtype":"article","id":"hebsur_influenza_2014","issn":"1530-6550","journal":"Reviews in Cardiovascular Medicine","key":"hebsur_influenza_2014","keywords":"Humans, Inflammation, Influenza Vaccines, Influenza, Human, Myocardial Infarction, Prognosis, Risk Factors, Vaccination","language":"eng","number":"2","pages":"168--175","pmid":"25051134","shorttitle":"Influenza and coronary artery disease","title":"Influenza and coronary artery disease: exploring a clinical association with myocardial infarction and analyzing the utility of vaccination in prevention of myocardial infarction","type":"article","volume":"15","year":"2014","bibbaseid":"hebsur-vakil-oetgen-kumar-lazarous-influenzaandcoronaryarterydiseaseexploringaclinicalassociationwithmyocardialinfarctionandanalyzingtheutilityofvaccinationinpreventionofmyocardialinfarction-2014","role":"author","urls":{},"keyword":["Humans","Inflammation","Influenza Vaccines","Influenza","Human","Myocardial Infarction","Prognosis","Risk Factors","Vaccination"],"downloads":0},"search_terms":["influenza","coronary","artery","disease","exploring","clinical","association","myocardial","infarction","analyzing","utility","vaccination","prevention","myocardial","infarction","hebsur","vakil","oetgen","kumar","lazarous"],"keywords":["humans","inflammation","influenza vaccines","influenza","human","myocardial infarction","prognosis","risk factors","vaccination"],"authorIDs":[],"dataSources":["JnJ2Whzgn25T7zFga"]}